PF
Paolo Fundaro
Director

Paolo Fundaro insider trades: Intercept Pharmaceuticals (ICPT) stock sales

Director, Intercept Pharmaceuticals Last trade Aug 17, 2020 26 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2013
1
Company
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Paolo reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 17, 2020ICPT↓ Sell$71.2M
May 13, 2020ICPT↓ Sell$50.4M
Mar 29, 2019ICPT↓ Sell$233K
Jul 24, 2015ICPT↓ Sell$166K
Aug 11, 2014ICPT↓ Sell$78K
May 9, 2014ICPT↓ Sell$75K
Feb 14, 2014ICPT↓ Sell$2.7M
Aug 12, 2013ICPT↓ Sell$220K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Paolo Fundaro's insider trades

Paolo Fundaro is a director at Intercept Pharmaceuticals (ICPT). Since Aug 12, 2013, Paolo has reported no open-market purchases and 8 sales worth $125.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (12 filings), option exercises (10 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ICPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.